Breast cancer patients with high density mammograms do not have increased risk of death

September 7, 2012, National Institutes of Health

(Medical Xpress)—High mammographic breast density, which is a marker of increased risk of developing breast cancer, does not seem to increase the risk of death among breast cancer patients, according to a study led by Gretchen L. Gierach, Ph.D., of the National Cancer Institute (NCI), part of the National Institutes of Health. The research was conducted in collaboration with investigators from the NCI-sponsored Breast Cancer Surveillance Consortium (BCSC).

In the study of over 9,000 women with a confirmed diagnosis of breast cancer, high was not associated with the risk of death from breast cancer or death from all causes combined. The study appeared Aug. 20, 2012, in the Journal of the .

Mammographic reflects the tissue composition of the breast as seen on a mammogram. High mammographic density appears as extensive white areas on an X-ray. Glandular and connective tissue, together known as fibroglandular tissue, block the passage of X-rays to a greater extent than . Breasts with a greater proportion of fibroglandular tissue are said, therefore, to be mammographically denser. For most women, mammographic breast density decreases as they get older, reflecting gradual replacement of fibroglandular tissue by fatty tissue during the normal aging process.

Although high mammographic breast density is a well-established risk factor for developing breast cancer, it was unclear prior to this study whether breast density is also associated with the risk of death among women diagnosed with breast cancer. To address this question the scientists analyzed data from the BCSC, a population-based registry of facilities in the United States. The scientists restricted their analysis to five BCSC registries that consistently collect data on (BMI). BMI is a poor for breast cancer that is inversely related to breast density and therefore might potentially affect associations between density and breast cancer death.

Patients included in the study were 30 years or older at breast cancer diagnosis, which occurred primarily between January 1996 and December 2005. The patients were followed, on average, for 6.6 years, at which time 1,795 deaths were reported, including 889 from breast cancer and 810 from other causes. To analyze breast density, the scientists used the most widely available measure of breast density currently in clinical use, a score known as the Breast Imaging-Reporting and Data System score, which is given by a radiologist based on visual review of a mammogram. Data on tumor characteristics and other personal and health factors were also analyzed.

The analysis of mammographic density showed that breast cancer patients with high-density breasts did not have a higher risk of death from breast cancer than patients with lower density breasts, after adjusting for other health factors and tumor characteristics. The lack of an association between mammographic breast density and breast cancer death is consistent with findings from an earlier, smaller study that examined this association.

This study also found an increase in risk of breast cancer death associated with lower breast density among specific subgroups, particularly breast cancer patients who are obese. The authors speculate that one possible explanation for the increased risk associated with low breast density among some subgroups is that breasts with a higher percentage of fat may provide a tumor microenvironment that facilitates cancer growth and progression.

"Overall, it was reassuring to find that high mammographic breast density, one of the strongest risk factors for breast cancer, was not related to risk of death from breast cancer or death from any cause among ," said Gierach. "Given that we identified subsets of women with for whom low density was associated with poor prognoses, our findings underscore the need for an improved understanding of the biological components that are responsible for breast density."

Explore further: Breast density does not influence breast cancer death among breast cancer patients

More information: Gierach GL, et al. Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. Journal of National Cancer Institute. August 20, 2012. DOI:10.1093/jnci/djs327

Related Stories

Breast density does not influence breast cancer death among breast cancer patients

August 20, 2012
The risk of dying from breast cancer was not related to high mammographic breast density in breast cancer patients, according to a study published August 20 in the Journal of the National Cancer Institute.

Women born to older mothers have a higher risk of developing breast cancer

February 6, 2012
A new study analyses the influence that certain birth and infancy characteristics have on mammographic density – an important indicator of breast cancer risk. The results reveal that women born to mothers aged over 39 ...

Breast density tied to specific types of breast cancer

July 27, 2011
Women with breasts that appear dense on mammograms are at a higher risk of breast cancer and their tumors are more likely to have certain aggressive characteristics than women with less dense breasts, according to a study ...

Breast tenderness in women getting combo hormone therapy associated with increase in breast density

October 14, 2011
Post-menopausal women who experience new onset breast tenderness after starting combination hormone therapy may have an increased risk of breast cancer compared to women who don't experience breast tenderness, a study by ...

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.